FI3672653T3 - Liposomiformulaatio nivelen voiteluun - Google Patents
Liposomiformulaatio nivelen voiteluun Download PDFInfo
- Publication number
- FI3672653T3 FI3672653T3 FIEP18847493.6T FI18847493T FI3672653T3 FI 3672653 T3 FI3672653 T3 FI 3672653T3 FI 18847493 T FI18847493 T FI 18847493T FI 3672653 T3 FI3672653 T3 FI 3672653T3
- Authority
- FI
- Finland
- Prior art keywords
- dmpc
- joint
- composition according
- membrane
- case
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 23
- 238000009472 formulation Methods 0.000 title claims 2
- 238000005461 lubrication Methods 0.000 title claims 2
- 239000012528 membrane Substances 0.000 claims 14
- GZDFHIJNHHMENY-UHFFFAOYSA-N Dimethyl dicarbonate Chemical compound COC(=O)OC(=O)OC GZDFHIJNHHMENY-UHFFFAOYSA-N 0.000 claims 13
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 8
- 239000002502 liposome Substances 0.000 claims 8
- 150000003904 phospholipids Chemical class 0.000 claims 8
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 claims 7
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 7
- 229930195725 Mannitol Natural products 0.000 claims 7
- 150000002327 glycerophospholipids Chemical class 0.000 claims 7
- 235000010355 mannitol Nutrition 0.000 claims 7
- 239000000594 mannitol Substances 0.000 claims 7
- 201000008482 osteoarthritis Diseases 0.000 claims 4
- NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 claims 3
- 208000012659 Joint disease Diseases 0.000 claims 3
- 239000000872 buffer Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 3
- 208000006820 Arthralgia Diseases 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 229920005862 polyol Polymers 0.000 claims 2
- 150000003077 polyols Chemical class 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- CITHEXJVPOWHKC-UUWRZZSWSA-N 1,2-di-O-myristoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC CITHEXJVPOWHKC-UUWRZZSWSA-N 0.000 claims 1
- LJARBVLDSOWRJT-PSXMRANNSA-N 1,2-di-O-pentadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCC LJARBVLDSOWRJT-PSXMRANNSA-N 0.000 claims 1
- 208000025978 Athletic injury Diseases 0.000 claims 1
- 206010060820 Joint injury Diseases 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 1
- 206010041738 Sports injury Diseases 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 238000011882 arthroplasty Methods 0.000 claims 1
- 239000007975 buffered saline Substances 0.000 claims 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- 210000000629 knee joint Anatomy 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000002953 phosphate buffered saline Substances 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 229930195734 saturated hydrocarbon Natural products 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 230000000472 traumatic effect Effects 0.000 claims 1
- 230000008736 traumatic injury Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/10—Materials for lubricating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762548429P | 2017-08-22 | 2017-08-22 | |
| PCT/IL2018/050923 WO2019038763A1 (en) | 2017-08-22 | 2018-08-21 | LIPOSOMAL FORMULATION FOR JOINT LUBRICATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3672653T3 true FI3672653T3 (fi) | 2023-06-07 |
Family
ID=65439381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP18847493.6T FI3672653T3 (fi) | 2017-08-22 | 2018-08-21 | Liposomiformulaatio nivelen voiteluun |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US11123293B2 (enExample) |
| EP (2) | EP4223284A1 (enExample) |
| JP (2) | JP7082336B2 (enExample) |
| KR (2) | KR102607729B1 (enExample) |
| CN (2) | CN114601799B (enExample) |
| AU (3) | AU2018319594B2 (enExample) |
| BR (1) | BR112020003767B1 (enExample) |
| CA (2) | CA3073368C (enExample) |
| DK (1) | DK3672653T3 (enExample) |
| EA (1) | EA202090476A1 (enExample) |
| ES (1) | ES2948715T3 (enExample) |
| FI (1) | FI3672653T3 (enExample) |
| HR (1) | HRP20230566T1 (enExample) |
| HU (1) | HUE062030T2 (enExample) |
| IL (3) | IL272630B2 (enExample) |
| LT (1) | LT3672653T (enExample) |
| MA (1) | MA49959B1 (enExample) |
| MX (2) | MX2020002041A (enExample) |
| MY (1) | MY197149A (enExample) |
| PH (1) | PH12020500331A1 (enExample) |
| PL (1) | PL3672653T3 (enExample) |
| PT (1) | PT3672653T (enExample) |
| SG (1) | SG11202000773QA (enExample) |
| SI (1) | SI3672653T1 (enExample) |
| WO (1) | WO2019038763A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI782181B (zh) * | 2019-02-11 | 2022-11-01 | 以色列商莫比斯醫療有限公司 | 用於關節潤滑的脂質體調配物 |
| JP2021013788A (ja) * | 2020-11-10 | 2021-02-12 | 株式会社三洋物産 | 遊技機 |
| CN118678947A (zh) * | 2022-01-02 | 2024-09-20 | 莫比斯医疗有限公司 | 脂质体捕集体积的测定 |
| CN119816311A (zh) | 2023-01-19 | 2025-04-11 | 莫比斯医疗有限公司 | 一种治疗关节障碍中的疼痛的长效脂质体组合物 |
| KR20250018222A (ko) * | 2023-07-26 | 2025-02-05 | 차의과학대학교 산학협력단 | 미토콘드리아가 캡슐화된 세포막 융합유도 리포좀을 포함하는 골관절염 치료를 위한 약학 조성물 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5403592A (en) | 1987-08-25 | 1995-04-04 | Macnaught Pty Limited | Lubricant composition for rheumatism |
| EP0319638A1 (en) * | 1987-12-08 | 1989-06-14 | Estee Lauder Inc. | Liposome containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions |
| US5941909A (en) * | 1995-02-14 | 1999-08-24 | Mentor Corporation | Filling material for soft tissue implant prostheses and implants made therewith |
| AUPN723395A0 (en) | 1995-12-19 | 1996-01-18 | Macnaught Medical Pty Limited | Lubrication methods |
| US6379648B1 (en) * | 1999-02-01 | 2002-04-30 | The Curators Of The University Of Missouri | Biodegradable glass compositions and methods for radiation therapy |
| US6800298B1 (en) * | 2000-05-11 | 2004-10-05 | Clemson University | Biological lubricant composition and method of applying lubricant composition |
| US20040047807A1 (en) * | 2001-01-24 | 2004-03-11 | Dominik Meyer | Use of neurotoxic substances in producing a medicament for treating joint pains |
| US6509027B2 (en) * | 2001-02-12 | 2003-01-21 | Supergen, Inc. | Injectable pharmaceutical composition comprising coated particles of camptothecin |
| AU2002255993B2 (en) * | 2001-03-29 | 2008-05-01 | Optimer Pharmaceuticals | Formulations comprising entrapped active ingredients and uses thereof |
| EP1423081A4 (en) | 2001-06-25 | 2005-05-25 | Depuy Int Ltd | COMPOSITION WITH GLYCOSAMINOGYCANES AND HYALURONIDASE INHIBITORS FOR THE TREATMENT OF ARTHRITIC JOINTS |
| JP2004535434A (ja) | 2001-06-25 | 2004-11-25 | デピユイ | 関節炎にかかった関節の処置のためのグリコサミノグリカン類のリポソームカプセル化 |
| IL159334A0 (en) * | 2001-06-25 | 2004-06-01 | Yissum Res Dev Co | A method for preparation of vesicles loaded with biological material and different uses thereof |
| DE10255106A1 (de) * | 2002-11-24 | 2004-06-09 | Novosom Ag | Liposomale Glucocorticoide |
| US7205006B2 (en) | 2003-09-25 | 2007-04-17 | Prime Pharmaceutical Corporation | Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same |
| US7749485B2 (en) | 2004-06-03 | 2010-07-06 | Bracco Research S.A. | Liposomal assembly for therapeutic and/or diagnostic use |
| CN101027065A (zh) * | 2004-06-15 | 2007-08-29 | 陈献 | 磷脂组合物及其制备和使用方法 |
| US20070071840A1 (en) | 2005-09-27 | 2007-03-29 | Sridevi Dhanaraj | Method for treatment of cartilage disorders with centella extract |
| ITPD20060202A1 (it) | 2006-05-22 | 2007-11-23 | Univ Degli Studi Trieste | Miscele polimeriche di polisaccaridi anionici e cationici e loro impiego |
| JP5072275B2 (ja) * | 2006-07-03 | 2012-11-14 | テルモ株式会社 | 閉鎖小胞の分離方法、製剤の製造方法および評価方法 |
| US20080027554A1 (en) * | 2006-07-31 | 2008-01-31 | Talmadge Karen D | Kit and methods of treatment of an intervertebral disc |
| CN101541308B (zh) * | 2006-09-28 | 2012-02-01 | 哈达斯特医疗研究服务和开发有限公司 | 甘油磷脂用于关节润滑的用途 |
| US8834920B2 (en) | 2006-12-21 | 2014-09-16 | Alza Corporation | Liposome composition for targeting egfr receptor |
| FR2918276B1 (fr) | 2007-07-02 | 2010-01-22 | Anteis Sa | "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires" |
| US20110171288A1 (en) | 2008-02-20 | 2011-07-14 | Fatemeh Mohammadi | Topical compositions and methods for whitening skin |
| BR112012032153A2 (pt) | 2010-06-17 | 2017-08-08 | Yeda Res And Development Company Ltd | método para a lubrificação de uma ou mais superfícies não biológicas, método para a lubrificação de uma ou mais superfícies de um tecido biológico em um indivíduo mamífero, uso de lipossomas na fase em gel e lipossoma misto |
| IL206739A (en) * | 2010-06-30 | 2016-06-30 | David Segal | An injectable drug containing silitol as an active substance |
| US20140038917A1 (en) | 2011-04-19 | 2014-02-06 | Anteis S.A. | Sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint |
| US8623839B2 (en) | 2011-06-30 | 2014-01-07 | Depuy Mitek, Llc | Compositions and methods for stabilized polysaccharide formulations |
| GB201206486D0 (en) * | 2012-04-12 | 2012-05-30 | Sequessome Technology Holdings Ltd | Vesicular formulations and uses thereof |
| KR102176971B1 (ko) * | 2012-07-05 | 2020-11-11 | 타이완 리포좀 캄파니 리미티드 | 관절염의 치료 방법 |
| CN104688721A (zh) | 2014-10-11 | 2015-06-10 | 黄萍 | 一种含紫杉醇脂质体的抗类风湿性关节炎药物凝胶剂及其制备方法 |
-
2018
- 2018-08-21 HR HRP20230566TT patent/HRP20230566T1/hr unknown
- 2018-08-21 DK DK18847493.6T patent/DK3672653T3/da active
- 2018-08-21 PL PL18847493.6T patent/PL3672653T3/pl unknown
- 2018-08-21 CN CN202210282704.7A patent/CN114601799B/zh active Active
- 2018-08-21 EA EA202090476A patent/EA202090476A1/ru unknown
- 2018-08-21 WO PCT/IL2018/050923 patent/WO2019038763A1/en not_active Ceased
- 2018-08-21 JP JP2020511447A patent/JP7082336B2/ja active Active
- 2018-08-21 CN CN201880053772.8A patent/CN111065423B/zh active Active
- 2018-08-21 FI FIEP18847493.6T patent/FI3672653T3/fi active
- 2018-08-21 PT PT188474936T patent/PT3672653T/pt unknown
- 2018-08-21 MA MA49959A patent/MA49959B1/fr unknown
- 2018-08-21 CA CA3073368A patent/CA3073368C/en active Active
- 2018-08-21 AU AU2018319594A patent/AU2018319594B2/en active Active
- 2018-08-21 KR KR1020207006061A patent/KR102607729B1/ko active Active
- 2018-08-21 EP EP23160029.7A patent/EP4223284A1/en active Pending
- 2018-08-21 CA CA3219776A patent/CA3219776A1/en active Pending
- 2018-08-21 ES ES18847493T patent/ES2948715T3/es active Active
- 2018-08-21 IL IL272630A patent/IL272630B2/en unknown
- 2018-08-21 US US16/337,188 patent/US11123293B2/en active Active
- 2018-08-21 IL IL301801A patent/IL301801B2/en unknown
- 2018-08-21 MY MYPI2020000726A patent/MY197149A/en unknown
- 2018-08-21 SI SI201830942T patent/SI3672653T1/sl unknown
- 2018-08-21 EP EP18847493.6A patent/EP3672653B1/en active Active
- 2018-08-21 HU HUE18847493A patent/HUE062030T2/hu unknown
- 2018-08-21 MX MX2020002041A patent/MX2020002041A/es unknown
- 2018-08-21 BR BR112020003767-2A patent/BR112020003767B1/pt active IP Right Grant
- 2018-08-21 LT LTEPPCT/IL2018/050923T patent/LT3672653T/lt unknown
- 2018-08-21 KR KR1020237040609A patent/KR102808544B1/ko active Active
- 2018-08-21 SG SG11202000773QA patent/SG11202000773QA/en unknown
- 2018-08-21 IL IL312816A patent/IL312816A/en unknown
-
2020
- 2020-02-13 PH PH12020500331A patent/PH12020500331A1/en unknown
- 2020-02-21 MX MX2023009082A patent/MX2023009082A/es unknown
-
2021
- 2021-08-15 US US17/445,089 patent/US12214077B2/en active Active
-
2022
- 2022-05-17 JP JP2022080859A patent/JP7383759B2/ja active Active
-
2023
- 2023-05-26 AU AU2023203309A patent/AU2023203309B2/en active Active
-
2024
- 2024-12-17 US US18/984,974 patent/US20250114304A1/en active Pending
-
2025
- 2025-01-07 AU AU2025200077A patent/AU2025200077A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3672653T3 (fi) | Liposomiformulaatio nivelen voiteluun | |
| US10736846B2 (en) | Methods of treating arthritis | |
| US5958379A (en) | Pharmaceutical composition | |
| US20210299047A1 (en) | Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same | |
| US11992483B2 (en) | Emulsions for local anesthetics | |
| JP2018502870A (ja) | トラネキサム酸の多小胞リポソーム処方物 | |
| US12285419B2 (en) | Bupivacaine multivesicular liposome formulations and uses thereof | |
| AU2011317237B2 (en) | Use of storage stable viscous phospholipid depot to treat wounds | |
| NZ761298B2 (en) | Liposomal formulation for joint lubrication | |
| AU2020253613B2 (en) | Liposomes encapsulating adenosine | |
| TW202220668A (zh) | 用於疼痛控制之關節內皮質類固醇的藥學組成物 | |
| CN120456947A (zh) | 使用缓释脂质体麻醉组合物进行与全膝关节置换术相关疼痛的治疗 | |
| HK1188408B (en) | A sustained release formulation of a non-steroidal anti-inflammatory drug |